RELAPSED HEMATOLOGIC MALIGNANCY
Clinical trials for RELAPSED HEMATOLOGIC MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new RELAPSED HEMATOLOGIC MALIGNANCY trials appear
Sign up with your email to follow new studies for RELAPSED HEMATOLOGIC MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill combo shows promise for tough brain cancer
Disease control Recruiting nowThis study tests an experimental oral drug called emavusertib (CA-4948), taken alone or with ibrutinib, in adults with relapsed or refractory primary central nervous system lymphoma (PCNSL). The trial has multiple parts to find the safest dose and see if the drug shrinks tumors. …
Matched conditions: RELAPSED HEMATOLOGIC MALIGNANCY
Phase: PHASE1, PHASE2 • Sponsor: Curis, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Gene therapy recipients monitored for 15 years in safety study
Knowledge-focused Recruiting nowThis study does not test a new treatment. Instead, it follows 500 people who have already received genetically modified cell therapy for blood cancers. Researchers will check for any delayed side effects over 15 years, as required by the FDA. The goal is to understand long-term r…
Matched conditions: RELAPSED HEMATOLOGIC MALIGNANCY
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New european effort matches kids with relapsed leukemia to smarter treatments
Knowledge-focused Recruiting nowThis study helps doctors choose the best available therapy for children and young adults with relapsed or hard-to-treat blood cancers. A team of experts reviews each patient's tumor markers and history to recommend a personalized treatment plan. The study does not give any new dr…
Matched conditions: RELAPSED HEMATOLOGIC MALIGNANCY
Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC